Expression of granzyme A and perforin in mouse heart transplants immunosuppressed with donor-specific transfusion and anti-CD4 monoclonal antibody

Transplantation

Volumn 61, Issue 4, 1996, Pages 625-629

  Chen, Raymond H ^a   Bushell, Andrew ^a,b   Fuggle, Susan V ^a   Wood, Kathryn J ^a   Morris, Peter J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OKT 4; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BLOOD TRANSFUSION; GRAFT REJECTION; GRANZYMES; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IN SITU HYBRIDIZATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PORE FORMING CYTOTOXIC PROTEINS; RATS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029924074     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00018     Document Type: Article

References (39)

1. Ascher NL, Ferguson RM, Hoffman RA, Simmons RL. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 1979; 27: 254.
2. Griffiths GM, Mueller C. Expression of perform and granzymes in vivo: potential markers of activated cells. Immunol Today 1991; 12: 415.
3. Mueller C, Kagi D, Aebischer T, et al. Detection of perform and granzyme A mRNA in infiltrating cells during infection of mice with lymphocyte choriomeningitis virus. Eur J Immunol 1989; 19: 1253.
4. Mueller C, Shelby J, Weissman IL, Perinat-Frey T, Eichwald EJ. Expression of the protease gene HF as a marker in rejecting allogeneic murine heart transplants. Transplantation 1991; 51: 514.
5. Griffiths GM, Namikawa R, Mueller C, Liu CC, Young JD, Billingham M, Weissman I. Granzyme A and perform as markers for rejection in cardiac transplantation. Eur J Immunol 1991; 21: 687.
6. Chen RH, Ivens KW, Alpert S, et al. The use of granzyme A as a marker of heart transplant rejection in cyclosporin A or anti-CD4 monoclonal antibody-treated rats. Transplantation 1993; 55: 146.
7. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adult using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
8. Bushell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy: a protocol with significant clinical application. Transplantation 1994; 58: 133.
9. Pearson TC, Madsen JC, Wood KJ. Effect of anti-CD4 monoclonal antibody dosage when combined with donor antigen for the induction of transplantation tolerance. Transplant Proc 1991; 23: 565.
10. Qin S, Wise M, Cobbold SP, Leong L, Kong YM, Parnes JR, Waldmann HR. Induction of tolerance in peripheral T-cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737.
11. Corry RJ, Winn HJ, Russell PS. Primarily vascularised allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
12. Springer T, Galfre G, Secher DS, Milstein C. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of a novel leukocyte differentation antigen. Eur J Immunol. 1978; 8: 539.
13. Tomonari K. A rat antibody against a structure functionally related to the mouse T cell receptor/T3 complex. Immunogenetics 1988; 28: 455.
14. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 1984; 312: 548.
15. Mason DW, Morris PJ. Inhibition of the accumulation, in rat kidney allografts, of specific but not non-specific cytotoxic cells by cyclosporine. Transplantation 1984; 37: 46.
16. Tilney NL, Strom TB, MacPherson SG, Carpenter CB. Surface properties and functional characteristics of infiltrating cells harvested from acutely rejecting cardiac allografts in inbred rats. Transplantation 1975; 20: 323.
17. Strom TB, Tilney NL, Carpenter CB, Busch GJ. Identification and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med 1975; 292: 1257.
18. Ascher NL, Ferguson RM, Hoffman RA, Simmons RL. Cellular events within the rejecting allograft. Transplantation 1979; 27: 254.
19. Hayry P, von Willebrand E, Soots A. In situ effector mechanisms in rat kidney allograft rejection: III. Kinetics of the inflammatory response and generation of donor-directed killer cells. Scand J Immunol 1979; 10: 95.
20. Mason DW, Dallman MJ, Arthur RP, Morris PJ. Mechanisms of allograft rejection; the roles of cytotoxic T cells and delayed type hypersensitivity. Immunol Rev 1984; 77: 167.
21. Liu CC, Rafii S, Granelli-Piperno A, Trapani JA, Ding-E Young J. Perform and serine esterase gene expression in stimulated human T cells. J Exp Med 1989; 170: 2105.
22. Martin DE, Zalman LS, Jung G, Muller-Eberhard HJ. Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin-2: correlation with cytotoxicity and lymphocyte phenotype. Proc Natl Acad Sci USA 1987; 84: 2946.
23. Garcia-Sanz JA, Velotti F, MacDonald HR, Masson D, Tschopp J, Nabholz M. Appearance of granule-associated molecules during activation of cytotoxic T-lymphocyte precursors by defined stimuli. Immunology 1988; 64: 129.
24. Lavie G, Leib Z, Servadio C. The mechanism of human NK cell-mediated cytotoxicity. Mode of action of surface-associated proteases in the early stages of the lytic reaction. J Immunol 1985; 135: 1470.
25. Hudig D, Allison NJ, Pickett TM, Winkler U, Kam CM, Powers JC. The function of lymphocyte proteases: inhibition and restoration of granule-mediated lysis with isocoumarin serine protease inhibitors. J Immunol 1991; 147: 1360.
26. Muller-Eberhard, HJ. The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection. Immunol Rev 1988; 103: 87.
27. Acha-Orbea H, Scarpellino L, Hertig S, Dupuis M, Tschopp J. Inhibition of lymphocyte mediated cytotoxicity by perforin antisense oligonucleotides. EMBO J 1990; 9: 3815.
28. Shiver JW, Henkart PA. A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with cytolysin/perforin gene. Cell 1991; 64: 1175.
29. Nakajima H, Arakawa K, Yasumura T, Oka T. Biochemical monitoring of acute rejection with BLT serine esterase gene. Transplant Proc 1987; 21: 1187.
30. Mottram PL, Mirisklavos A, Dumble LJ, Clunie GJA. Effects of CsA, antilymphocyte serum, and donor-specific transfusion on murine DTH and skin graft survival. Int Arch Allergy Immunol 1986; 79: 296.
31. Alexander JW, Babcock GF, First MR, et al. The induction of immunological hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. Transplantation 1992; 53: 423.
32. Peugh WN, Wood KJ, Morris PJ. Genetic aspects of the blood transfusion effect. Transplantation 1988; 46: 438.
33. Monostori E, Desal D, Brown MH, Cantrell DA, Crumpton MJ. Activation of human T lymphocytes via the CD2 antigen results in tyrosine phosphorylation of T cell antigen receptor ζ-chains. J Immunol 1990; 144: 1010.
34. Norton SD, Zuckerman L, Urdahl KB, Shefner R, Miller J, Jenkins MK. The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. J Immunol 1992; 149: 1556.
35. Mohler KM, Streilein JW. Differential expression of helper versus effector activity in mice rendered neonatally tolerant of class II MHC antigens. Transplantation 1989; 47: 633.
36. Ting CC, Hargrove ME. IL-4 regulation of a protein kinase C independent pathway for the generation of alpha CD3-induced activated killer cells. Cell Immunol 1992; 140: 130.
37. Widmer MB, Grabstein KH. Regulation of cytolytic T-lymphocyte generation by B cell stimulatory factor. Nature 1987; 326: 795.
38. Fields LE, Loh DY. Organ injury associated with extrathymic induction of immune tolerance in doubly transgenic mice. Proc Natl Acad Sci USA 1992; 89: 5730.
39. Bugeon L, Cuturi MC, Hallet MM, Paineau J, Chabannes D, Soulillou JP. Peripheral tolerance of an allograft in adult rats: characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992; 54: 219.